✦ LIBER ✦

ESPAC-1: A European, randomised study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer

✍ Scribed by J.P. Neoptolemos; D.D. Moffitt; J.A. Dunn; J. Almond; H.G. Beger; K.H. Link; P. Pederzoli; C. Bassi; C. Dervernis; L. Fernandez-Cruz; F. Lacaine; D. Spooner; D.J. Kerr; H. Freiss; M.W. Büchler

Book ID: 117658793
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 164 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81432-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival and quality of life (QoL) of pa

Survival and quality of life (QoL) of patients in ESPAC-1: A european, randomised study of assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer

✍ J.P. Neoptolemos; D.D. Moffitt; J.A. Dunn; J. Almond; H.G. Beger; C. Bassi; C. D 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Progress report: A randomized multicente

Progress report: A randomized multicenter European stydy comparing adjuvant radiotherapy, 6 Mo chemotherapy, and combination therapy vs No-adjuvant treatment in resectable pancreatic cancer (ESPAC-1)

✍ John P. Neoptolemos; Pat Baker; Hans Beger; Karl Link; Paolo Pederzoli; Claudio 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 839 KB

Phase 2 Study of Erlotinib Combined With

Phase 2 Study of Erlotinib Combined With Adjuvant Chemoradiation and Chemotherapy in Patients With Resectable Pancreatic Cancer

✍ Herman, Joseph M.; Fan, Katherine Y.; Wild, Aaron T.; Hacker-Prietz, Amy; Wood, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 480 KB

A phase I study for adjuvant chemotherap

A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures

✍ Takeshi Takahara; Hiroyuki Nitta; Yasushi Hasegawa; Naoko Itou; Masahiro Takahas 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 246 KB

Corrigendum to “Phase III randomised stu

Corrigendum to “Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)” [European Journal of Cancer, 44 (2008) 808–818]

✍ N.S. Reed; C. Mangioni; H. Malmström; G. Scarfone; A. Poveda; S. Pecorelli; S. T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Phase III randomised study to evaluate t

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)

✍ N.S. Reed; C. Mangioni; H. Malmström; G. Scarfone; A. Poveda; S. Pecorelli; S. T 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 370 KB